We report a case of transient left posterior hemiblock during an attack of Prinzmetal's angina and, subsequently, during an acute inferior myocardial infarction. To our knowledge, we are unaware of other similar clinical observations.
A 49-year-old man of heavy body build with a previous history of chest pain of three weeks' duration was admitted because of chest pain at rest radiating to both arms. Physical examination showed only afaint midsystolic ejection murmur. The patient's blood pressure was 90170 mm Hg, and his pulse rate was 55 beats per minute.
The electrocardiogram on admission (Fig LA) during the chest pain showed normal sinus rhythm at 55 beats per minute. The QRS duration was 0.10 second, and the frontal QRS axis was directed to about + 100". There was a qR pattern with ST-segment elevation in leads 2,3, and aVF and an rS pattern in leads 1 and aVL. Reciprocal ST-segment depression occurred in leads 1, aVL, and V, to V,. Following sublingual administration of nitroglycerin, the chest pain subsided. An ECG (Fig 1B) when the patient was free of symptoms showed normal sinus rhythm at 100 beats per minute, frontal QRS axis to about +65", and QRS duration of 0.08 second. There was a negative T wave in leads 2, 3, and aVF without ST-segment displacement. The chest x-ray film and serial cardiac enzyme levels were normal. Treatment with nifedipine (20 mg every six hours) and isosorbide dinitrate (120 mg four times daily) was begun. Twenty hours later, the patient had severe chest pain lasting 30 minutes and not responding to administration of nitroglycerin, which was relieved with morphine sulfate. The ECG (Fig 2A) during pain showed normal sinus rhythm at 95 beats per minute, frontal QRS axis to + 110°, and QRS duration of 0.10 second. There was a QR pattern with ST-segment elevations in leads 2.3, and aVF and an rS pattern in leads 1 and aVL. Subsequent enzymatic elevations were typical of acute myocardial infarction. Two days later, the ECG (Fig  28) revealed normal sinus rhvthm at 60 beats Der minute and frontal QRS axis about to -20'. There were a Q wave, ST-segment elevations, and an inverted T wave in leads 2.3, and aVE The patient made an uneventful recovery and was discharged ten days later.
In 1973, Gorfinkel et a14 described a transient left posterior hemiblock, although incomplete (QRS axis to +70°), in a patient with Prinzmetal's angina who had 90 percent obstruction of the right coronary artery. Since then, transient left posterior hemiblock has not been specifically mentioned, but we have found four cases in a review of reports of Prinzmetal's angina with inferior ST-segment elevations."' Two out of four patients who developed this disturbance in conduction had subtotal obstruction of the right coronary artery. 'These four cases and our patient show transient right QRS axis deviation compatible with the diagnosis of left posterior hemiblock,s,s that is: (1) a shift of the main QRS forces to the right, between +90° and + 12V, causing tall R waves in leads 2,3, and aVF and deep S waves in leads 1 and aVL; (2) a small but definitive change in the direction of the initial 10-msec to 20-msec QRS vectors, which are shifted superiorly and to the left (since in our case a Q wave was already present in the inferior leads in the absence of complete left posterior hemiblock, the appearance of the latter did not change the initial vector of the QRS complex; (3) left posterior hemiblock provokes an S,-Q,,, pattern by shifting the initial QRS forces to the left and superiorly, whereas the terminal force is directed to the right and inferiorly; and (4) the QRS interval is slightly prolonged, usually no more than 0.02 second.
Studying the very early changes in the QRS axis and ST segment following experimental coronary arterial occlusion, Conrad e t all0 showed three important changes in leads showing left posterior hemiblock during &peracute phase of inferior myocardial infarction. B, Electmcardiogram shows recent inferior myocardial infarction * without left posterior hemiblock.
overlying t h e affected area: (1) t h e "injuryw-related ST-segment changes; (2) the "injury"-related intramural (local) block; and (3) the increase in the size of the R wave, which is also dependent on the modifications of conduction produced by the "injury."
If the affected zone is in the inferior myocardial wall, these modifications will result in a slight increase in QRS duration, as well as in the height of the R wave in leads 2,3, and aVE The latter, in turn, "pulls down" the terminal portions of the ventricular complex (S wave) in lead 1. Therefore, some degree of right QRS axis deviation occurs." As a consequence of these changes, the surface ECG will show some of the features attributed to left posterior hemiblock, as in our case and in the reports described previ~usly.~'
The appearance of a "new" (small) q wave in the inferior leads (or the accentuation of a previously present q wave)
suggests left posterior hemiblock,R,s but it should be remembered that most inferoapical infarctions also involved the diaphragmatic portions of the interventricular septum. The latter may allow the more anterior (left-to-right) vectoral forces to increase in magnitude in a superior (caudal) direction. In summary, whether these electrocardiographic features seen in our case reflect left posterior hemiblock or an acute "local" block in the posteroinferior wall of the left ventricle requires more clinical investigation. T imolol maleate, a nonselective beta-adrenergic blocker, is used as an ophthalmic solution for the treatment of glaucoma. It possesses the therapeutic advantage oflowering intraocular pressure without changing pupillary size or causing diminution of vision, side effects which are prominent with miotic medications such as pilocarpine.' Over half the reports of adverse reactions to timolol ophthalmic solution reflect systemic beta blockade due to absorption from the conj~nctiva.~Thus, therapeutic doses of timolol ophthalmic solution may cause a significant decrease in airflow in patients with bronchospastic pulmonary
The present case is important to note because the patient suffered a potentially fatal respiratory arrest within 30 minutes of his first dose of timolol ophthalmic solution.
A 67-yearold man had been receiving outpatient treatment for chronic obstructive pulmonary disease, noncritical calcific aortic stenosis, essential hypertension, and glaucoma His medicines included hvdrochlorothiazide. theoohvlline sustained-action tablets, and ietaproterenol sulfate, dotl; orally and by inhalation.
Pulmonary function tests, performed seven months prior to admis-
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Administration MAcal Centec Baltimore. Rsprint nqucsts: D1: Carliner, VA Medical Cmtcr, 3900 3900 R a m Blud, Bolthnon 21218 sion, demonstrated moderate obstructive disease with air trapping. The forced vital capacity was 3.2 L, and the forced expiratory ~l u m e in one second was 1.76 L (55 percent). There was no significant change in flow rate following the administration of bronchodilator drugs. He had been clinically stable, except for worsening glaucoma.
On the day of admission, he had been seen in the ophthalmology clinic, and, because of progression of glaucoma despite pilocarpine therapy, timolol ophthalmic solution (0.5 percent) was prescribed. That evening, within approximately five minutes of his first dose of one drop in each eye, he noted the acute onset of shortness ofbreath. His symptoms were not relieved by three of four pu& from his metaproterenol inhaler. Over the next ten minutes, his dyspnea progressed rapidly, and his wife noted that he was markedly cyanotic. She summoned the paramedics; when they arrived, the patient was unresponsive and apneic. Assisted ventilation with an Ambu bag and supplemental oxygen were begun, and he was transferred to a nearby community hospital.
When he arrived in the emergency room, the pulse rate was 120 beatslmin and the blood pressure was 250/l20 mm Hg. There was no effective spontaneous respiration. The arterial blood gas levels were pH, 6.93; Pco, , 141 mm Hg; and Po, , 71 mm Hg. Following insertion of an endotracheal tube under morphine sedation, mechanical ventilation was begun. He received intravenously-administered arninophylline and steroids and aerosolized isoetharine hydrochloride. Forty minutes after intubation, hewas responsive and able to follow commands. His breath sounds were much improved, although bilateral wheezes were present. The arterial blood gas levels were pH, 7.07; Pco,, 83 mm Hg; and Po,, 197 mm Hg (fractional concentration ofoxygen in inspired gas [FIoJ, 0.50) . Two hours after intubation, the arterial blood gas levels (FIo,, 0.40) were: pH, 7.41; Pco*, 36 mm Hg; and P%, 191 mm Hg. Although intermittent wheezing persisted, the patient was successfully extubated 15 hours later.
We did not rechallenge our patient with timolol in view of the severity of his bronchospasm; however, the temporal relationship between his first dose of timolol and the subsequent respiratory arrest strongly implicated timolol as the inciting agent. Xmolol is known to be absorbed from the conjunctiva into the systemic circulationP bypassing the liver where it is normally metabolized. The relative potency of timolol is approximately six times that of propranolol%o that absorption of even the small doses of timolol used in ophthalmic solutions may cause systemic beta blockade. Patients with obstructive airway disease may be critically dependent upon beta-adrenergic stimulation for the maintenance of airway patency and thus be susceptible to severe and potentially fatal bronchospasm following the administration of tirnolol solution. In such patients, timolol ophthalmic solution should be considered only as a last resort when other methods of therapy have failed to control glaucoma. When timolol therapy is contemplated in a patient with obstructive airway disease, it may be helpful to perform spirometric evaluation before and after topical administration of timolol to determine if clinically inapparent bronchospasm is provoked.' We believe that patients with clinical evidence of increased airway reactivity should receive the initial dose of timolol ophthalmic solution under medical observation and that personnel and facilities should be available to perform resuscitation, ifneeded. Even ifthere is no apparent adverse reaction to the first dose, continued close medical follow-up is mandatory throughout the course of timolol therapy.
